Onconova Therapeutics

Onconova Therapeutics company information, Employees & Contact Information

Updated May 2026

Quick answer

Onconova Therapeutics is a Biotechnology Research company and founded in 1998. It has approximately 20 employees on record. Contact data was last refreshed in May 2026. Find Onconova Therapeutics's verified employee emails, phone numbers, headquarters address, and key decision makers below.

Onconova Therapeutics, Inc. (NASDAQ: ONTX) is a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer.

Company Details

Employees
20
Founded
1998
Address
12 Penns Trail, Newtown,pa 18940,united States
Phone
2677593681
Email
in****@****nova.us
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Newtown, PA
Looking for a particular Onconova Therapeutics employee's phone or email?

Onconova Therapeutics Questions

News

Annovis Appoints Mark Guerin as Chief Financial Officer - The Globe and Mail

Annovis Appoints Mark Guerin as Chief Financial Officer The Globe and Mail

‘Best-In-Class Virology And Oncology’: Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Combine to Form Traws Pharma, Inc. - orrick.com

‘Best-In-Class Virology And Oncology’: Onconova Therapeutics, Inc. and Trawsfynydd Therapeutics, Inc. Combine to Form Traws Pharma, Inc. orrick.com

We Think Onconova Therapeutics (NASDAQ:ONTX) Needs To Drive Business Growth Carefully - Yahoo Finance

We Think Onconova Therapeutics (NASDAQ:ONTX) Needs To Drive Business Growth Carefully Yahoo Finance

Onconova Therapeutics Appoints James J. Marino, JD, MBA as Chairman of the Board of Directors - citybiz

Onconova Therapeutics Appoints James J. Marino, JD, MBA as Chairman of the Board of Directors citybiz

Onconova Moving Forward with Phase 3 INSPIRE Pivotal Trial - GlobeNewswire

Onconova Moving Forward with Phase 3 INSPIRE Pivotal Trial GlobeNewswire

Onconova Presents Positive Clinical Trial Results for Radiation Injury Protector Ex-RAD® - CNBC

Onconova Presents Positive Clinical Trial Results for Radiation Injury Protector Ex-RAD® CNBC

Why Onconova Therapeutics (ONTX) Stock Is Up Sharply - Market Realist

Why Onconova Therapeutics (ONTX) Stock Is Up Sharply Market Realist

Onconova closes $79.6m IPO - - Global Venturing

Onconova closes $79.6m IPO - Global Venturing

Onconova Looks to Launch Phase 1 Trial of ON 123300 in Breast Cancer - breastcancer-news.com

Onconova Looks to Launch Phase 1 Trial of ON 123300 in Breast Cancer breastcancer-news.com

Analysis of the metabolomic profile in serum of irradiated nonhuman primates treated with Ex-Rad, a radiation countermeasure - Nature

Analysis of the metabolomic profile in serum of irradiated nonhuman primates treated with Ex-Rad, a radiation countermeasure Nature

Onconova On The Edge After Phase III Rigosertib MDS Failure - Citeline News & Insights

Onconova On The Edge After Phase III Rigosertib MDS Failure Citeline News & Insights

GVK Bio, Onconova to develop new cancer drugs - Business Today

GVK Bio, Onconova to develop new cancer drugs Business Today

Top Onconova Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant